|
KRRO Korro Bio Inc 1703647 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-19,625,000.00 |
| Balance Sheet |
|
Current Assets
|
$120,163,000.00 |
|
Assets
|
$183,622,000.00 |
|
Current Liabilities
|
$14,787,000.00 |
|
Liabilities
|
$63,989,000.00 |
|
Equity
|
$119,633,000.00 |
|
Shares Out
|
14422571.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-16,074,000.00 |
|
Investing Cash Flow
|
$-32,240,000.00 |
| Market Analysis |
Market Cap
|
$150,715,866.95 |
|
Price
|
$10.47 |
|
BVPS
|
8.29 |
|
PB
|
1.26 |
|
EPS
|
-1.69 |
|
FCF
|
$-16,095,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:33 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-12.48 |
|
|
2026-05-07 |
-1.69 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-2.74 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-1.92 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KRRO documents filed with the SEC.
KRRO Filings
Clear
